---
id: toxicity-endpoints
title: Toxicity Endpoints
description: Canonical page for toxicity endpoints predicted using IVIVE and computational toxicology methods
slug: /toxicological-endpoints/toxicity-endpoints
sidebar_label: Toxicity Endpoints
page_type: endpoint
entity_class: endpoint
status: draft
last_reviewed: 2026-08-08
verification_status: unverified
aliases:
  - Toxicity Endpoints
  - Adverse Outcomes
  - Toxicological Endpoints
---

## Overview

Toxicity endpoints represent the observable adverse effects of chemical exposures that are relevant to human health and ecology. In computational toxicology, these endpoints are predicted using methods such as In Vitro to In Vivo Extrapolation (IVIVE), machine learning, and adverse outcome pathway (AOP) frameworks. Understanding and predicting toxicity endpoints is essential for risk assessment and regulatory decision-making.

## Scope and Notes

This page covers:
- Major toxicity endpoints relevant to computational toxicology
- Methods for predicting and assessing these endpoints
- Integration with IVIVE and other computational approaches
- Current challenges and future directions

Toxicity endpoints should not be confused with specific assays or measurements. The focus is on the observable adverse effects that result from chemical exposures.

## Key Definitions and Claims

### Core Definition

```yaml
claim_id: clm-endpoints-001
page_id: toxicity-endpoints
claim_type: definition
statement: Toxicity endpoints represent observable adverse effects of chemical exposures relevant to human health and ecology.
subject: Toxicity Endpoints
predicate: represent
object: observable adverse effects
qualifiers:
  context: computational toxicology
citations:
  - cit-ivive-review-2024
verification_status: unverified
confidence: high
depends_on: []
```

### Role in IVIVE

```yaml
claim_id: clm-endpoints-002
page_id: toxicity-endpoints
claim_type: fact
statement: IVIVE studies have focused on predicting various toxicity endpoints, including neurotoxicity, developmental toxicity, hepatotoxicity, and endocrine effects.
subject: Toxicity Endpoints
predicate: predicted_by
object: IVIVE studies
qualifiers:
  context: computational toxicology
citations:
  - cit-ivive-review-2024
verification_status: unverified
confidence: high
depends_on: []
```

## Major Toxicity Endpoints

### Neurotoxicity

**Definition**: Adverse effects on the nervous system, including the brain, spinal cord, and peripheral nerves.

**Key Aspects**:
- Cognitive and behavioral effects
- Neurodevelopmental effects
- Neurodegenerative effects
- Peripheral neuropathy

**Computational Approaches**:
- IVIVE for predicting brain exposure
- Machine learning models for neurotoxicity prediction
- AOP frameworks for neural pathways

### Developmental Toxicity

**Definition**: Adverse effects on fetal development, including structural abnormalities, growth retardation, and functional deficits.

**Key Aspects**:
- Teratogenicity (birth defects)
- Developmental neurotoxicity
- Endocrine disruption during development
- Growth and developmental delays

**Computational Approaches**:
- IVIVE for predicting fetal exposure
- High-throughput screening for developmental effects
- AOP frameworks for developmental pathways

### Hepatotoxicity

**Definition**: Liver damage or dysfunction resulting from chemical exposure.

**Key Aspects**:
- Hepatic necrosis and apoptosis
- Steatosis (fat accumulation)
- Cholestasis (bile flow disruption)
- Fibrosis and cirrhosis

**Computational Approaches**:
- IVIVE for predicting liver exposure
- Machine learning models for hepatotoxicity prediction
- AOP frameworks for liver pathways

### Endocrine Disruption

**Definition**: Interference with hormonal systems that can lead to developmental, reproductive, neurological, and immune disorders.

**Key Aspects**:
- Estrogen, androgen, and thyroid hormone disruption
- Developmental and reproductive effects
- Metabolic disruption
- Neuroendocrine effects

**Computational Approaches**:
- IVIVE for predicting hormone system exposure
- High-throughput screening for endocrine activity
- AOP frameworks for endocrine pathways

### Carcinogenicity

**Definition**: The ability of a chemical to cause cancer.

**Key Aspects**:
- Genotoxicity (DNA damage)
- Epigenetic changes
- Chronic tissue damage and inflammation
- Hormonal effects on cancer development

**Computational Approaches**:
- IVIVE for predicting carcinogen exposure
- Machine learning models for carcinogenicity prediction
- AOP frameworks for carcinogenic pathways

### Genotoxicity

**Definition**: Damage to DNA that can lead to mutations, cancer, and other adverse effects.

**Key Aspects**:
- DNA strand breaks
- DNA adduct formation
- Chromosomal aberrations
- Micronucleus formation

**Computational Approaches**:
- IVIVE for predicting genotoxin exposure
- High-throughput screening for genotoxicity
- AOP frameworks for DNA damage pathways

## Predictive Methods for Toxicity Endpoints

### In Vitro to In Vivo Extrapolation (IVIVE)

IVIVE enables the prediction of toxicity endpoints by:
- Translating in vitro concentrations to in vivo exposures
- Predicting tissue-specific doses from environmental exposures
- Supporting the interpretation of in vitro data in biological contexts

### Machine Learning

Machine learning models predict toxicity endpoints by:
- Identifying patterns in complex toxicological datasets
- Combining chemical structure data with biological activity data
- Predicting multiple endpoints from high-throughput screening data

### Adverse Outcome Pathways

AOP frameworks support endpoint prediction by:
- Providing mechanistic context for toxicity data
- Linking molecular initiating events to adverse outcomes
- Supporting weight-of-evidence assessments

### Physiologically-Based Toxicokinetic Models

PBTK models enhance endpoint prediction by:
- Providing quantitative descriptions of ADME processes
- Predicting tissue-specific exposures from environmental exposures
- Supporting dose-response modeling for toxicity endpoints

## Integration with Risk Assessment

### Hazard Identification

- Identifying potential toxicity endpoints for chemicals
- Characterizing the nature of adverse effects
- Understanding dose-response relationships

### Exposure Assessment

- Predicting internal doses from external exposures
- Estimating margins of safety
- Supporting risk characterization

### Risk Characterization

- Integrating hazard and exposure information
- Estimating risks to human health and ecology
- Supporting regulatory decision-making

## Current Challenges and Limitations

### Data Quality and Quantity

- Need for comprehensive data on toxicity endpoints
- Challenges in obtaining data for all relevant endpoints
- Issues with data reproducibility and standardization

### Model Predictive Capacity

- Limitations in current predictive models
- Challenges in extrapolating across species and endpoints
- Issues with uncertainty and variability in predictions

### Regulatory Acceptance

- Need for clear criteria for model validation
- Challenges in establishing confidence in predictions
- Jurisdictional differences in regulatory expectations

### Complex Mixtures

- Challenges in predicting effects of chemical mixtures
- Need for integrated approaches to mixture toxicity
- Issues with data availability for mixture studies

## Future Directions

- Development of more predictive models for toxicity endpoints
- Integration of multiple computational approaches
- Improved methods for handling uncertainty and variability
- Enhanced regulatory acceptance through validation frameworks
- Application to complex mixtures and environmental exposures
- Development of predictive models for emerging technologies

## Related Pages

- [In Vitro to In Vivo Extrapolation](@{REF}:/models-and-methods/ivive.md)
- [Machine Learning in Toxicology](@{REF}:/models-and-methods/ml-in-toxicology.md)
- [Adverse Outcome Pathway Framework](@{REF}:/concepts/aop-framework.md)
- [Physiologically-Based Toxicokinetic Models](@{REF}:/models-and-methods/pbtk-models.md)
- [High-Throughput Screening](@{REF}:/assays/hts.md)

## Open Questions or Review Notes

- Standardization of data formats and reporting for toxicity endpoints
- Development of clear validation criteria for predictive models
- Integration of multiple computational approaches for endpoint prediction
- Addressing uncertainty and variability in model predictions
- Development of methods for handling complex mixtures and environmental exposures

## References

```yaml
citation_id: cit-ivive-review-2024
source_type: review
title: "Advancing Toxicity Predictions: A Review on In Vitro to In Vivo Extrapolation in Next-Generation Risk Assessment"
authors:
  - [Authors not specified]
year: 2024
container: Environmental Health
doi: 10.1021/envhealth.4c00043
url: https://doi.org/10.1021/envhealth.4c00043
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-08
pages_or_sections: null
notes: Central source for toxicity endpoints definitions and applications
```